Free Trial

Cue Biopharma (CUE) News Today

Cue Biopharma logo
$0.84 +0.02 (+2.66%)
Closing price 04:00 PM Eastern
Extended Trading
$0.84 0.00 (-0.12%)
As of 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CUE Latest News

Cue Biopharma initiated with a Buy at Lucid Capital
Cue Biopharma CFO to Resign
Cue Biopharma Inc.
Cue Biopharma receives $12M upfront in CUE-501 license pact
Cue Biopharma Announces Proposed Public Offering
Cue Biopharma to Host Business Update Call and Webcast
Cue Biopharma reports Q4 EPS (13c), consensus (14c)
Artiva expands Board with appointment of Dan Baker, M.D
Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Update
Get Cue Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUE and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CUE Media Mentions By Week

CUE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CUE
News Sentiment

0.66

0.70

Average
Medical
News Sentiment

CUE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CUE Articles
This Week

5

1

CUE Articles
Average Week

Get the Latest News and Ratings for CUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cue Biopharma and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CUE) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners